186 related articles for article (PubMed ID: 11798461)
1. Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma.
Tanabe T; Yamamoto JK
J Interferon Cytokine Res; 2001 Dec; 21(12):1039-46. PubMed ID: 11798461
[TBL] [Abstract][Full Text] [Related]
2. Potent anti-feline immunodeficiency virus and anti-human immunodeficiency virus effect of IFN-tau.
Pontzer CH; Yamamoto JK; Bazer FW; Ott TL; Johnson HM
J Immunol; 1997 May; 158(9):4351-7. PubMed ID: 9126998
[TBL] [Abstract][Full Text] [Related]
3. Effects of human recombinant alpha-2b interferon and feline recombinant omega interferon on in vitro replication of feline herpesvirus-1.
Siebeck N; Hurley DJ; Garcia M; Greene CE; Köstlin RG; Moore PA; Dietrich UM
Am J Vet Res; 2006 Aug; 67(8):1406-11. PubMed ID: 16881854
[TBL] [Abstract][Full Text] [Related]
4. The biological effects of five feline IFN-alpha subtypes.
Baldwin SL; Powell TD; Sellins KS; Radecki SV; Cohen JJ; Milhausen MJ
Vet Immunol Immunopathol; 2004 Jun; 99(3-4):153-67. PubMed ID: 15135982
[TBL] [Abstract][Full Text] [Related]
5. Follow-Up of Viral Parameters in FeLV- or FIV-Naturally Infected Cats Treated Orally with Low Doses of Human Interferon Alpha.
Gomez-Lucia E; Collado VM; Miró G; Martín S; Benítez L; Doménech A
Viruses; 2019 Sep; 11(9):. PubMed ID: 31514435
[TBL] [Abstract][Full Text] [Related]
6. Oral Recombinant Feline Interferon-Omega as an alternative immune modulation therapy in FIV positive cats: clinical and laboratory evaluation.
Gil S; Leal RO; McGahie D; Sepúlveda N; Duarte A; Niza MM; Tavares L
Res Vet Sci; 2014 Feb; 96(1):79-85. PubMed ID: 24332273
[TBL] [Abstract][Full Text] [Related]
7. [Feline immunodeficiency virus infection: interferon gamma secretion in a T-lymphoblastoid infected cell line].
Mórtola EC; Endo Y; Zuccolilli GO; Gimeno EJ
Rev Argent Microbiol; 1999; 31(3):127-34. PubMed ID: 10509391
[TBL] [Abstract][Full Text] [Related]
8. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.
Dean GA; LaVoy A; Burkhard MJ
Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995
[TBL] [Abstract][Full Text] [Related]
9. Use of recombinant interferon omega in feline retrovirosis: from theory to practice.
Doménech A; Miró G; Collado VM; Ballesteros N; Sanjosé L; Escolar E; Martin S; Gomez-Lucia E
Vet Immunol Immunopathol; 2011 Oct; 143(3-4):301-6. PubMed ID: 21719116
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment with feline interferon omega and the course of subsequent infection with feline herpesvirus in cats.
Haid C; Kaps S; Gönczi E; Hässig M; Metzler A; Spiess BM; Richter M
Vet Ophthalmol; 2007; 10(5):278-84. PubMed ID: 17760705
[TBL] [Abstract][Full Text] [Related]
11. Antiviral efficacy of nine nucleoside reverse transcriptase inhibitors against feline immunodeficiency virus in feline peripheral blood mononuclear cells.
Schwartz AM; McCrackin MA; Schinazi RF; Hill PB; Vahlenkamp TW; Tompkins MB; Hartmann K
Am J Vet Res; 2014 Mar; 75(3):273-81. PubMed ID: 24564313
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of stromal cell derived factor-1 on the replication of divergent strains of feline immunodeficiency virus in a feline T-lymphoid cell line.
Endo Y; Goto Y; Nishimura Y; Mizuno T; Watari T; Hasegawa A; Hohdatsu T; Koyama H; Tsujimoto H
Vet Immunol Immunopathol; 2000 May; 74(3-4):303-14. PubMed ID: 10802296
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L.
Uncini Manganelli RE; Zaccaro L; Tomei PE
J Ethnopharmacol; 2005 Apr; 98(3):323-7. PubMed ID: 15814267
[TBL] [Abstract][Full Text] [Related]
14. CD8+ T cells from feline immunodeficiency virus (FIV) infected cats suppress exogenous FIV replication of their peripheral blood mononuclear cells in vitro.
Hohdatsu T; Sasagawa T; Yamazaki A; Motokawa K; Kusuhara H; Kaneshima T; Koyama H
Arch Virol; 2002 Aug; 147(8):1517-29. PubMed ID: 12181672
[TBL] [Abstract][Full Text] [Related]
15. Anti-feline immunodeficiency virus (FIV) soluble factor(s) produced from antigen-stimulated feline CD8(+) T lymphocytes suppresses FIV replication.
Choi IS; Hokanson R; Collisson EW
J Virol; 2000 Jan; 74(2):676-83. PubMed ID: 10623729
[TBL] [Abstract][Full Text] [Related]
16. Measurement of reverse transcriptase of feline immunodeficiency virus by poly A-linked colorimetric assay.
Saito T; Suzuki K; Imai M; Inaba Y
J Vet Med Sci; 1997 Jun; 59(6):425-9. PubMed ID: 9234215
[TBL] [Abstract][Full Text] [Related]
17. In vitro characterization of FIV-pPPR, a pathogenic molecular clone of feline immunodeficiency virus, and two drug-resistant pol gene mutants.
McCrackin Stevenson MA; McBroom DG
Am J Vet Res; 2001 Apr; 62(4):588-94. PubMed ID: 11327469
[TBL] [Abstract][Full Text] [Related]
18. Effect of interleukin-12 and interleukin-10 on the virus replication and apoptosis in T-cells infected with feline immunodeficiency virus.
Mortola E; Endo Y; Mizuno T; Ohno K; Watari T; Tsujimoto H; Hasegawa A
J Vet Med Sci; 1998 Nov; 60(11):1181-5. PubMed ID: 9853297
[TBL] [Abstract][Full Text] [Related]
19. Anti-human immunodeficiency virus (HIV) agents are also potent and selective inhibitors of feline immunodeficiency virus (FIV)-induced cytopathic effect: development of a new method for screening of anti-FIV substances in vitro.
Tanabe-Tochikura A; Tochikura TS; Blakeslee JR; Olsen RG; Mathes LE
Antiviral Res; 1992 Aug; 19(2):161-72. PubMed ID: 1332602
[TBL] [Abstract][Full Text] [Related]
20. Feline CD8+ cells induced with FIV infected, irradiated T cells produce multiple anti-FIV factors.
Li Z; Phadke A; Weaver EA; Ball JM; Collisson EW
Dev Comp Immunol; 2005; 29(9):809-24. PubMed ID: 15936436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
